Abstract
Synaptic transmission involves the regulated release of transmitter molecules to the synaptic cleft, where they interact with postsynaptic receptors which subsequently transduce the information. Removal of the transmitter from the cleft enables termination of the signal, which usually occurs through reuptake back to the presynaptic terminal or into glial elements in a sodium-dependent process. This process assures constant and high levels of neurotransmitters in the neuron and low concentrations in the cleft.
Chapter authored in August 2000.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schuldiner, S., Shirvan, A., and Linial, M. (1995) Vesicular neurotransmitter transporters: from bacteria to human. Phys. Rev. 75, 369–392.
Johnson, R. (1988) Accumulation of Biological Amines in Chromaffin Granules: A Model for Hormone and Neurotransmitter Transport. Physiol. Rev. 68, 232–307.
Njus, D., Kelley, P. M., and Harnadek, G. J. (1986) Bioenergetics of secretory vesicles. Biochim. Biophys. Acta 853, 237–265.
Njus, D., Knoth, J., and Zallakian, M. (1981) Proton-linked transport in chromaffin granules. Curr. Top. Bioenerg. 11, 107–147.
Ohya, Y., Umemoto, N., Tanida, I., Ohta, A., lida, H., and Anraku, Y. (1991) Calcium sensitive cls mutants of Saccharomyces cerevisiae showing a Petphenotypeare ascribable to defects of vacuolar membrane H+-ATPase activity. J. Biol. Chem. 266, 13,971–13, 977.
Edwards, R. (1992) The transport of neurotransmitters into synaptic vesicles. Curr. Opin. Neurobiol. 2, 586–594.
Liu, Y. and Edwards, R. H. (1997) The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu. Rev. Neurosci. 20, 125–156.
Schuldiner, S. (1994) A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62, 2067–2078.
Usdin, T. B., Eiden, L. E., Bonner, T. I., and Erickson, J. D. (1995) Molecular biology of the vesicular ACh transporter. Trends. Neurosci. 18, 218–224.
Bellocchio, E. E., Reimer, R. J., Fremeau, R. T., Jr., and Edwards, R. H. (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289, 957–960.
Takamori, S., Rhee, J. S., Rosenmund, C., and Jahn, R. (2000) Identification of a vesicular transporter that defines a glutamatergic phenotype in neurons. Nature 407, 189–194.
Ni, B., Rosteck, P. R., Jr., Nadi, N. S., and Paul, S. M. (1994) Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter. Proc. Natl. Acad. Sci. USA 91, 5607–5611.
Lee, R. Y., Sawin, E. R., Chalfie, M., Horvitz, H. R., and Avery, L. (1999) EAT-4, a homolog of a mammalian sodium-dependent inorganic phosphate cotransporter, is necessary for glutamatergic neurotransmission in caenorhabditis elegans. J. Neurosci. 19, 159–167.
Bellocchio, E. E., Hu, H., Pohorille, A., Chan, J., Pickel, V. M., and Edwards, R. H. (1998) The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J. Neurosci. 18, 8648–8659.
Kirshner, N. (1962) Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem. 237, 2311–2317.
Pletscher, A. (1977) Effect of neuroleptics and other drugs on monoamine uptake by membrane of adrenal chromaffin granules. Br. J. Pharmacol. 59, 419–424.
Marshall, I. (1970) Studies on the blocking action of 2-(4-phenyl piperidino) cyclohexanol (AH5183). Br. J. Pharmacol. 38, 503–516.
Marshall, I. and Parsons, S. (1987) The vesicular acetylcholine transport system. Trends. Neurosci. 10, 174–177.
Parsons, S., Bahr, B., Rogers, G., Clarkson, E., Noremberg, K., and Hicks, B. (1993) Acetylcholine transporter-vesamicol receptor pharmacology and structure. Prog. Brain Res. 98, 175–181.
Darchen, F., Scherman, D., and Henry, J. P. (1989) Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry 28, 1692–1697.
Scherman, D. and Henry, J. P. (1984) Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding. Mol. Pharmacol. 25, 113–122.
Rudnick, G., Steiner-Mordoch, S. S., Fishkes, H., Stern-Bach, Y., and Schuldiner, S. (1990) Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter. Biochemistry 29, 603–608.
Stitzel, R. E. (1977) The Biological Fate of Reserpine. Pharm. Rev. 28, 179–205.
Carlsson, A. (1965) Drugs which block the storage of 5-hydroxytryptamine and related amines. Hand. Exp. Pharmacol. 19, 529–592.
Frize, E. (1954) Mental depression in hypertensive patients treated for long periods with high doses of reserpine. N. Engl. J. Med. 251, 1006–1008.
Weaver, J. A.,and Deupree, J. D. (1982) Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts. Eur. J. Pharm. 80, 437, 438.
Stern-Bach, Y., Greenberg-Ofrath, N., Flechner, I., and Schuldiner, S. (1990) Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem. 265, 3961–3966.
Darchen, F., Scherman, D., Desnos, C., and Henry, J. P. (1988) Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules. Biochem. Pharmacol. 37, 4381–4387.
Scherman, D. and Henry, J. P. (1981) pH-dependence of the ATP-driven uptake of noradrenaline by bovine chromaffin-granule ghosts. Eur. J. Biochem. 116, 535–539.
Henry, J. P. and Scherman, D. (1989) Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem. Pharmacol. 38, 2395–2404.
Desnos, C., Laran, M. P., and Scherman, D. (1992) Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal-medullary cells–stimulus biosynthesis coupling. J. Neurochem. 59, 2105–2112.
Desnos, C., Raynaud, B., Vidal, S., Weber, M. J., and Scherman, D. (1990) Induction of the vesicular monoamine transporter by elevated potassium concentration in cultures of rat sympathetic neurons. Dey. Brain. Res. 52, 161–166.
Stietzen, M., Schober, M., Fischer-Colbrie, R., Scherman, D., Sperk, G., and Winkler, H. (1987) Rat adrenal medulla: levels of chromogranins, enkephalins, dopamine b-hydroxylase and of the amine transporter are changed by nervous activity and by hypophysectomy. Neuroscience 22, 131–139.
Scherman, D., Jaudon, P., and Henry, J. P. (1983) Characterization of the monoamine carrier of chromaffin granule membrane by binding of [23H]dihydrotetrabenazine. Proc. Natl. Acad. Sci. USA 80, 584–588.
Rogers, G. A. and Parsons, S. M. (1989) Inhibition of acetylcholine storage by acetylcholine analogs in-vitro. Mol. Pharmacol. 36, 333–341.
Rogers, G. A., Parsons, S. M., Anderson, D. C., Nilsson, L. M., Bahr, B. A., Kornreich, W. D., Kaufman, R., Jacobs, R. S., and Kirtman, B. (1989) Synthesis, invitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogs of trans- 2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem. 32, 1217–1230.
Parsons, S. M., Bahr, B. A., Rogers, G. A., Clarkson, E. D., Noremberg, K., and Hicks, B. W. (1993) Acetylcholine Transporter Vesamicol Receptor Pharmacology and Structure. Prog. Brain Res. 98, 175–181.
Bahr, B., and Parsons, S. (1986) Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles. J. Neurochem. 46, 1214–1218.
Bahr, B. and Parsons, S. (1986) Demonstration of a receptor in Torpedo synaptic vesicles for the acetylcholine storage blocker L-trans-2-(4-phenyl[3,43H]piperidino) cyclohexanol. Proc. Natl. Acad. Sci. USA 83, 2267–2270.
Bahr, B. A., Clarkson, E. D., Rogers, G. A., Noremberg, K., and Parsons, S. M. (1992) A kinetic and allosteric model for the acetylcholine transportervesamicol receptor in synaptic vesicles. Biochemistry 31, 5752–5762.
Bahr, B. A., Noremberg, K., Rogers, G. A., Hicks, B. W., and Parsons, S. M. (1992) Linkage of the acetylcholine transporter vesamicol receptor to proteoglycan in synaptic vesicles. Biochemistry 31, 5778–5784.
Kaufman, R., Rogers, G. A., Fehlmann, C., and Parsons, S. M. (1989) Fractional vesamicol receptor occupancy and acetylcholine active-transport inhibition in synaptic vesicles. Mol. Pharmacol. 36, 452–458.
Clarkson, E. D., Rogers, G. A., and Parsons, S. M. (1992) Binding and active-transport of large analogs of acetylcholine by cholinergic synaptic vesicles invitro. J. Neurochem. 59, 695–700.
Bahr, B. A. and Parsons, S. M. (1992) Purification of the vesamicol receptor. Biochemistry 31, 5763–5769.
Rogers, G. A. and Parsons, S. M. (1992) Photoaffinity-labeling of the acetylcholine transporter. Biochemistry 31, 5770–5777.
Rogers, G. A. and Parsons, S. M. (1993) Photoaffinity-labeling of the vesamicol receptor of cholinergic synaptic vesicles. Biochemistry 32, 8596–8601.
Erickson, J. D., Varoqui, H., Schafer, M. K., Modi, W., Diebler, M. F., Weihe, E., Rand, J., Eiden, L. E., Bonner, T. I., and Usdin, T. B. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a “cholinergic” gene locus. J. Biol. Chem. 269, 21,929–21, 932.
Roghani, A., Feldman, J., Kohan, S. A., Shirzadi, A., Gundersen, C. B., Brecha, N., and Edwards, R. H. (1994) Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA 91, 10,620–10, 624.
Varoqui, H., Diebler, M. F., Meunier, F. M., Rand, J. B., Usdin, T. B., Bonner, T. I., Eiden, L. E., and Erickson, J. D. (1994) Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett. 342, 97–102.
Krejci, E., Gasnier, B., Botton, D., Isambert, M. F., Sagne, C., Gagnon, J., Massoulie, J., and Henry, J. P. (1993) Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett. 335, 27–32.
Stern-Bach, Y., Keen, J. N., Bejerano, M., Steiner-Mordoch, S., Wallach, M., Findlay, J. B., and Schuldiner, S. (1992) Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 89, 9730–9733.
Erickson, J. D., Eiden, L. E., and Hoffman, B. J. (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 89, 10, 993–10, 997.
Liu, Y., Peter, D., Roghani, A., Schuldiner, S., Prive, G., Eisenberg, D., Brecha, N., and Edwards, R. (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70, 539–551.
Schuldiner, S., Liu, Y., and Edwards, R. H. (1993) Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts. J. Biol. Chem. 268, 29–34.
Vincent, M. and Near, J. (1991) Purification of a [H-3]dihydrotetrabenazinebinding protein from bovine adrenal medulla. Mol. Pharmacol. 40, 889–894.
Isambert, M. F., Gasnier, B., Botton, D., and Henry, J. P. (1992) Characterization and purification of the monoamine transporter of bovine chromaffin granules. Biochemistry 31, 1980–1986.
Howell, M., Shirvan, A., Stern-Bach, Y., Steiner-Mordoch, S., Strasser, J. E., Dean, G. E., and Schuldiner, S. (1994) Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett. 338, 16–22.
Peter, D., Jimenez, J., Liu, Y., Kim, J., and Edwards, R. H. (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269, 7231–7237.
Scherman, D. and Boschi, G. (1988) Time required for transmitter accumulation inside monoaminergic storage vesicles differs in peripheral and in central systems. Neuroscience 27, 1029–1035.
Scherman, D. (1986) Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J. Neurochem. 47, 331–339.
Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E., and Weihe, E. (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 93, 5166–5171.
Nirenberg, M. J., Chan, J., Liu, Y., Edwards, R. H., and Pickel, V. M. (1997) Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals. Synapse 26, 194–198.
Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brecha, N., and Edwards, R. H. (1995) Differential expression of two vesicular monoamine transporters. J. Neurosci. 15, 6179–6188.
Weihe, E., Schafer, M. K., Erickson, J. D., and Eiden, L. E. (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5, 149–164.
Nirenberg, M. J., Liu, Y., Peter, D., Edwards, R. H., and Pickel, V. M. (1995) The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc. Natl. Acad. Sci. USA 92, 8773–8777.
Liu, Y., Schweitzer, E. S., Nirenberg, M. J., Pickel, V. M., Evans, C. J., and Edwards, R. H. (1994) Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J. Cell. Biol. 127, 1419–1433.
Holtje, M., von Jagow, B., Pahner, I., Lautenschlager, M., Hortnagl, H., Nurnberg, B., Jahn, R., and Ahnert-Hilger, G. (2000) The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2). J. Neurosci. 20, 2131–2141.
Mahata, S. K., Mahata, M., Fischercolbrie, R., and Winkler, H. (1993) Reserpine causes differential changes in the messenger RNA levels of chromogranin-B, secretogranin-II, carboxypeptidase-H, alpha-amidating monooxygenase, the vesicular amine transporter and of synaptin/synaptophysin in rat brain. Mol. Brain. Res. 19, 83–92.
Mahata, S. K., Mahata, M., Fischercolbrie, R., and Winkler, H. (1993) Vesicle monoamine transporter-1 and transporter-2-differential distribution and regulation of their messenger RNAs in chromaffin and ganglion cells of rat adrenal medulla. Neurosci. Lett. 156, 70–72.
Sievert, M. K., Thiriot, D. S., Edwards, R. H., and Ruoho, A. E. (1998) High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. Biochem. J. 330, 959–966.
Yelin, R. and Schuldiner, S. (2000) Vesicular monoamine transporters heterologously expressed in the yeast Saccharomyces cerevisiae display high affinity tetrabenazine binding. Biochem. Biophys. Acta. 1510, 426–441.
Sievert, M. K. and Ruoho, A. E. (1997) Peptide mapping of the [125I]Iodoazidoketanserin and [1251]2-N-[(3’- iodo-4’-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter. J. Biol. Chem. 272, 26,049–26, 055.
Sagne, C., Isambert, M. F., Vandekerckhove, J., Henry, J. P., and Gasnier, B. (1997) The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules. Biochemistry 36, 3345–3352.
Alfonso, A., Grundahl, K., Duerr, J. S., Han, H. P., and Rand, J. B. (1993) The Caenorhabditis elegans Unc-17 Gene–A Putative Vesicular Acetylcholine Transporter. Science 261, 617–619.
Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71–94.
Rand, J. (1989) Genetic analysis of the chal-unc17 gene complex in Caenorhabditis. Genetics 122, 73–80.
Weihe, E., Tao-Cheng, J. H., Schafer, M. K., Erickson, J. D., and Eiden, L. E. (1996) Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl. Acad. Sci. USA 93, 3547–3552.
Gilmor, M. L., Nash, N. R., Roghani, A., Edwards, R. H., Yi, H., Hersch, S. M., and Levey, A. I. (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 16, 2179–2190.
McIntire, S. L., Jorgensen, E., and Horvitz, H. R. (1993) Genes required for GABA function in Caenorhabditis elegans. Nature 364, 334–337.
McIntire, S. L., Jorgensen, E., Kaplan, J., and Horvitz, H. R. (1993) The GABAergic nervous system of Caenorhabditis elegans. Nature 364, 337–341.
McIntire, S. L., Reimer, R. J., Schuske, K., Edwards, R. H., and Jorgensen, E. M. (1997) Identification and characterization of the vesicular GABA transporter. Nature 389, 870–876.
Sagne, C., El Mestikawy, S., Isambert, M. F., Hamon, M., Henry, J. P., Giros, B., and Gasnier, B. (1997) Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett. 417, 177–183.
Burger, P., Hell, J., Mehl, E., Krasel, C., Lottspeich, F., and Jahn, R. (1991) Gaba and glycine in synaptic vesicles–storage and transport characteristics. Neuron 7, 287–293.
Hell, J. W., Maycox, P. R., and Jahn, R. (1990) Energy dependence and functional reconstitution of the gamma-aminobutyric acid carrier from synaptic vesicles. J. Biol. Chem. 265, 2111–2117.
Kish, P. E., Fischer-Bovenkerk, C., and Ueda, T. (1989) Active transport of gamma-aminobutyric acid and glycine into synaptic vesicles. Proc. Natl. Acad. Sci. USA 86, 3877–3881.
Christensen, H. and Fonnum, F. (1991) Uptake of glycine, GABA and glutamate by synaptic vesicles isolated from different regions of rat CNS. Neurosci. Lett. 129, 217–220.
Christensen, H., Fykse, E. M., and Fonnum, F. (1990) Uptake of glycine into synaptic vesicles isolated from rat spinal cord. J. Neurochem. 54, 1142–1147.
Christensen, H., Fykse, E. M., and Fonnum, F. (1991) Inhibition of gammaaminobutyrate and glycine uptake into synaptic vesicles. Eur. J. Pharmacol. 207, 73–79.
Fykse, E. M. and Fonnum, F. (1988) Uptake of gamma-aminobutyric acid by a synaptic vesicle fraction isolated from rat brain. J. Neurochem. 50, 1237–1242.
Hell, J. W., Maycox, P. R., Stadler, H., and Jahn, R. (1988) Uptake of GABA by rat brain synaptic vesicles isolated by a new procedure. EMBO J. 7, 3023–3029.
Kolston, J., Osen, K. K., Hackney, C. M., Ottersen, O. P., and StormMathisen, J. (1992) An atlas of glycine-and GABA-like immunoreactivity and colocalization in the cochlear nuclear complex of the guinea pig. Anat. Embryol. (Berl) 186, 443–465.
Ornung, G., Shupliakov, O., Linda, H., Ottersen, O. P., Storm-Mathisen, J., Ulfhake, B., and Cullheim, S. (1996) Qualitative and quantitative analysis of glycine-and GABA-immunoreactive nerve terminals on motoneuron cell bodies in the cat spinal cord: a postembedding electron microscopic study. J. Comp. Neurol. 365, 413–426.
Ornung, G., Shupliakov, O., Ottersen, O. P., Storm-Mathisen, J., and Cullheim, S. (1994) Immunohistochemical evidence for coexistence of glycine and GABA in nerve terminals on cat spinal motoneurones: an ultrastructural study. Neuroreport 5, 889–892.
Ottersen, O. P., Storm-Mathisen, J., and Somogyi, P. (1988) Colocalization of glycine-like and GABA-like immunoreactivities in Golgi cell terminals in the rat cerebellum: a postembedding light and electron microscopic study. Brain. Res. 450, 342–353.
Chaudhry, F. A., Reimer, R. J., Bellocchio, E. E., Danbolt, N. C., Osen, K. K., Edwards, R. H., and Storm-Mathisen, J. (1998) The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J. Neurosci. 18, 9733–9750.
Dumoulin, A., Rostaing, P., Bedet, C., Levi, S., Isambert, M. F., Henry, J. P., Triller, A., and Gasnier, B. (1999) Presence of the vesicular inhibitory amino acid transporter in GABAergic and glycinergic synaptic terminal boutons. J. Cell. Sci. 112, 811–823.
Ahnert-Hilger, G., Nurnberg, B., Exner, T., Schafer, T., and Jahn, R. (1998) The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles. EMBO J. 17, 406–413.
Liu, Y. and Edwards, R. H. (1997) Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells. J. Cell. Biol. 139, 907–916.
Kelly, R. B. (1993) Storage and release of neurotransmitters. Cell 72 Suppl, 43–53.
Varoqui, H. and Erickson, J. D. (1998) The cytoplasmic tail of the vesicular acetylcholine transporter contains a synaptic vesicle targeting signal. J. Biol. Chem. 273, 9094–9098.
Tan, P. K., Waites, C., Liu, Y., Krantz, D. E., and Edwards, R. H. (1998) A leucine-based motif mediates the endocyosis of vesicular monoamine and acetylcholine transporters. J. Biol. Chem. 273, 17,351–17, 360.
Letourneur, F. and Klausner, R. D. (1992) A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69, 1143–1157.
Rubin, L. A., Kurman, C. C., Biddison, W. E., Goldman, N. D., and Nelson, D. L. (1985) A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. Hybridoma 4, 91–102.
Dietrich, J., Kastrup, J., Nielsen, B. L., Odum, N., and Geisler, C. (1997) Regulation and function of the CD3gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J. Cell. Biol. 138, 271–281.
Cho, G. W., Kim, M. H., Chai, Y. G., Gilmor, M. L., Levey, A. I., and Hersh, L. B. (2000) Phosphorylation of the rat vesicular acetylcholine transporter. J. Biol. Chem. 275, 19,942–19, 948.
Krantz, D. E., Waites, C., Oorschot, V., Liu, Y., Wilson, R. I., Tan, P. K., Klumperman, J., and Edwards, R. H. (2000) A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles. J. Cell. Biol. 149, 379–396.
Barbosa, J., Jr., Clarizia, A. D., Gomez, M. V., Romano-Silva, M. A., Prado, V. F., and Prado, M. A. (1997) Effect of protein kinase C activation on the release of [3H]acetylcholine in the presence of vesamicol. J. Neurochem. 69, 2608–2611.
Dietrich, J., Hou, X., Wegener, A. M., and Geisler, C. (1994) CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13, 2156–2166.
Shin, J., Dunbrack, R. L., Jr., Lee, S., and Strominger, J. L. (1991) Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J. Biol. Chem. 266, 10,658–10, 665.
Yelin, R., Steiner-Mordoch, S., Aroeti, B., and Schuldiner, S. (1998) Glycosylation of a vesicular monoamine transporter: a mutation in a conserved proline residue affects the activity, glycosylation, and localization of the transporter. J. Neurochem. 71, 2518–2527.
Clarizia, A. D., Gomez, M. V., Romano-Silva, M. A., Parsons, S. M., Prado, V. F., and Prado, M. A. M. (1999) Control of the binding of a vesamicol analog to the vesicular acetylcholine transporter. Neuro report 10, 2783–2787.
Nakanishi, N., Onozawa, S., Matsumoto, R., Kurihara, K., Ueha, T., Hasegawa, H., and Minami, N. (1995) Effects of protein kinase inhibitors and protein phosphatase inhibitors on cyclic AMP-dependent down-regulation of vesicular monoamine transport in pheochromocytoma PC12 cells. FEBS Lett. 368, 411–414.
Krantz, D. E., Peter, D., Liu, Y., and Edwards, R. H. (1997) Phosphorylation of a vesicular monoamine transporter by casein kinase II. J. Biol. Chem. 272, 6752–6759.
Ahnert-Hilger, G., Schafer, T., Spicher, K., Grund, C., Schultz, G., and Wiedenmann, B. (1994) Detection of G-protein heterotrimers on large dense core and small synaptic vesicles of neuroendocrine and neuronal cells. Eur. J. Cell. Biol. 65, 26–38.
Gasnier, B., Scherman, D., and Henry, J. P. (1985) Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane. Biochemistry 24, 1239–1244.
Schuldiner, S., Fishkes, H., and Kanner, B. I. (1978) Role of a transmembrane pH gradient in epinephrine transport by chromaffin granule membrane vesicles. Proc. Natl. Acad. Sci. USA 75, 3713–3716.
Suchi, R., Stern-Bach, Y., Gabay, T., and Schuldiner, S. (1991) Covalent modification of the amine transporter with N,N’-dicyclohexylcarbodiimide. Biochemistry 30, 6490–6494.
Merickel, A., Rosandich, P., Peter, D., and Edwards, R. H. (1995) Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J. Biol. Chem. 270, 25,798–25, 804.
Kim, M. H., Lu, M., Lim, E. J., Chai, Y. G., and Hersh, L. B. (1999) Mutational analysis of aspartate residues in the transmembrane regions and cytoplasmic loops of rat vesicular acetylcholine transporter. J. Biol. Chem. 274, 673–680.
Merickel, A., Kaback, H. R., and Edwards, R. H. (1997) Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition. J. Biol. Chem. 272, 5403–5408.
Steiner-Mordoch, S., Shirvan, A., and Schuldiner, S. (1996) Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate. J. Biol. Chem. 271, 13,048–13, 054.
Song, H., Ming, G., Fon, E., Bellocchio, E., Edwards, R. H., and Poo, M. (1997) Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 18, 815–826.
Blakely, R. D. and Bauman, A. L. (2000) Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10, 328–336.
Gerchman, Y., Olami, Y., Rimon, A., Taglicht, D., Schuldiner, S., and Padan, E. (1993) Histidine-226 is part of the pH sensor of NhaA, a Na+/H+ antiporter in Escherichia coli. Proc. Natl. Acad. Sci. USA 90, 1212–1216.
Puttner, I. B., Sarkar, H. K., Padan, E., Lolkema, J. S., and Kaback, H. R. (1989) Characterization of site-directed mutants in the lac permease of Escherichia coli. 1. Replacement of histidine residues. Biochemistry 28, 2525–2533.
Isambert, M. F. and Henry, J. P. (1981) Effect of diethylpyrocarbonate on pH-driven monoamine uptake by chromaffin granule ghosts. FEBS Lett. 136, 13–18.
Suchi, R., Stern-Bach, Y., and Schuldiner, S. (1992) Modification of arginyl or histidyl groups affects the energy coupling of the amine transporter. Biochemistry 31, 12, 500–12, 503.
Keller, J. E. and Parsons, S. M. (2000) A critical histidine in the vesicular acetylcholine transporter. Neurochem. Int. 36, 113–117.
Kim, M. H., Lu, M., Kelly, M., and Hersh, L. B. (2000) Mutational analysis of basic residues in the rat vesicular acetylcholine transporter. Identification of a transmembrane ion pair and evidence that histidine is not involved in proton translocation. J. Biol. Chem. 275, 6175–6180.
Shirvan, A., Laskar, O., Steiner-Mordoch, S., and Schuldiner, S. (1994) Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat. FEBS Lett. 356, 145–150.
Dunten, R. L., Sahin-Toth, M., and Kaback, H. R. (1993) Role of the charge pair aspartic acid-237-lysine-358 in the lactose permease of Escherichia coli. Biochemistry 32, 3139–3145.
King, S. C., Hansen, C. L., and Wilson, T. H. (1991) The interaction between aspartic acid 237 and lysine 358 in the lactose carrier of Escherichia coli. Biochim. Biophys. Acta 1062, 177–186.
Sahin-Toth, M., Dunten, R. L., Gonzalez, A., and Kaback, H. R. (1992) Functional interactions between putative intramembrane charged residues in the lactose permease of Escherichia coli. Proc. Natl. Acad. Sci. USA 89, 10,54710, 551.
Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D., and Uhl, G. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89, 7782–7785.
Peter, D., Vu, T., and Edwards, R. H. (1996) Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. J. Biol. Chem. 271, 2979–2986.
Erickson, J. D. (1998) A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines. Adv. Pharmacol. 42, 227–232.
Varoqui, H. and Erickson, J. D. (1998) Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles. J. Physiol. Paris 92, 141–144.
Finn, J. P., 3rd and Edwards, R. H. (1997) Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 272, 16,301–16, 307.
Finn, J. P., 3rd and Edwards, R. H. (1998) Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 273, 3943–3947.
Duerr, J. S., Frisby, D. L., Gaskin, J., Duke, A., Asermely, K., Huddleston, D., Eiden, L. E., and Rand, J. B. (1999) The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J. Neurosci. 19, 72–84.
Takahashi, N., Miner, L. L., Sora, I., Ujike, H., Revay, R. S., Kostic, V., Jackson-Lewis, V., Przedborski, S., and Uhl, G. R. (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. USA 94, 9938–9943.
Fon, E. A., Pothos, E. N., Sun, B. C., Killeen, N., Sulzer, D., and Edwards, R. H. (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19, 1271–1283.
Wang, Y. M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., and Caron, M. G. (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19, 1285–1296.
Rudnick, G. and Wall, S. C. (1992) p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31, 6710–6718.
Hansson, S. R., Hoffman, B. J., and Mezey, E. (1998) Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system. Brain. Res. Dev. Brain. Res. 110, 135–158.
Itokawa, K., Sora, I., Schindler, C. W., Itokawa, M., Takahashi, N., and Uhl, G. R. (1999) Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden death. Brain. Res. Mol. Brain. Res. 71, 354–357.
Travis, E. R., Wang, Y. M., Michael, D. J., Caron, M. G., and Wightman, R. M. (2000) Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice. Proc. Natl. Acad. Sci. USA 97, 162–167.
Gainetdinov, R. R., Fumagalli, F., Wang, Y. M., Jones, S. R., Levey, A. I., Miller, G. W., and Caron, M. G. (1998) Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. J. Neurochem. 70, 1973–1978.
Fumagalli, F., Gainetdinov, R. R., Wang, Y. M., Valenzano, K. J., Miller, G. W., and Caron, M. G. (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19, 2424–2431.
Henry, J. P., Sagne, C., Bedet, C., and Gasnier, B. (1998) The vesicular monoamine transporter: from chromaffin granule to brain. Neurochem. Int. 32, 227–246.
Reimer, R. J., Fon, E. A., and Edwards, R. H. (1998) Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr. Opin. Neurobiol. 8, 405–412.
Griffith, J. K., Baker, M. E., Rouch, D. A., Page, M. G. P., Skurray, R. A., Paulsen, I., Chater, K. F., Baldwin, S. A., and Henderson, P. J. F. (1992) Evolution of transmembrane transport: relationships between transport proteins for sugars, carboxylate compounds, antibiotics and antiseptics. Curr. Opin. Cell. Biol. 4, 684–695.
Paulsen, I. T. and Skurray, R. A. (1994) Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes-an anlysis. Gene 124, 1–11.
Flowers, T. J., Troke, P. F., and Yeo, A. R. (1977) The mechanism of salt tolerance in halophytes. Ann. Rev. Plant. Physiol. 28, 89–121.
Wink, M. (1993) The plant vacuole: A multifunctional Compartment. J. Exp. Botany 44, 231–246.
Yelin, R., Rotem, D., and Schuldiner, S. (1999) EmrE, a small Escherichia coli multidrug transporter, protects Saccharomyces cerevisiae from toxins by sequestration in the vacuole. J. Bacteriol. 181, 949–956.
Yelin, R. and Schuldiner, S. (1995) The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett. 377, 201–207.
Gluck, S. L. (1992) The structure and biochemistry of the vacuolar H+ ATPase in proximal and distal urinary acidifcation. J. Bioenerg. Biomemb. 24, 351–359.
Gogarten, J. P., Kibak, H., Dittrich, P., Taiz, L., Bowman, E. J., Bowman, B. J., et al. (1989) Evolution of the vacuolar H+-ATPase: Implications for the origin of eukaryotes. Proc. Natl. Acad. Sci. USA 86, 6661–6665.
Nelson, N. (1992) Structural Conservation and functional diversity of V-ATPases. J. Bioenerg. Biomemb. 24, 407–414.
Felsenstein, J. (1989) PHYLIP — phylogeny inference package. Cladistics 5.
Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids. Res. 22, 4673–4680.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yelin, R., Schuldiner, S. (2002). Vesicular Neurotransmitter Transporters. In: Reith, M.E.A. (eds) Neurotransmitter Transporters. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-158-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-158-9_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-267-4
Online ISBN: 978-1-59259-158-9
eBook Packages: Springer Book Archive